These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 16769271

  • 1. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.
    Park JH, Koh KC, Choi MS, Lee JH, Yoo BC, Paik SW, Rhee JC, Joh JW.
    Am J Surg; 2006 Jul; 192(1):29-33. PubMed ID: 16769271
    [Abstract] [Full Text] [Related]

  • 2. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S.
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.
    Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, Xu W, Kan T.
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):33-7. PubMed ID: 20133226
    [Abstract] [Full Text] [Related]

  • 4. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [Abstract] [Full Text] [Related]

  • 5. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
    Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J.
    Cancer; 2000 Aug 01; 89(3):500-7. PubMed ID: 10931448
    [Abstract] [Full Text] [Related]

  • 6. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ, Ge L, Ding W, Li HJ.
    Ai Zheng; 2008 Dec 01; 27(12):1297-301. PubMed ID: 19079997
    [Abstract] [Full Text] [Related]

  • 7. Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
    Shimada M, Hasegawa H, Gion T, Shirabe K, Taguchi K, Takenaka K, Tanaka S, Sugimachi K.
    Hepatogastroenterology; 1999 Dec 01; 46(28):2469-75. PubMed ID: 10522022
    [Abstract] [Full Text] [Related]

  • 8. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ, Kim YH, Kang KJ, Lim TJ.
    Korean J Hepatol; 2008 Sep 01; 14(3):371-80. PubMed ID: 18815460
    [Abstract] [Full Text] [Related]

  • 9. [Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma].
    Wu FS, Zhao WH, Liang TB, Ren GP, Ma ZM, Teng LS.
    Zhonghua Wai Ke Za Zhi; 2005 May 01; 43(9):579-83. PubMed ID: 15938929
    [Abstract] [Full Text] [Related]

  • 10. Survival factors after resection of small hepatocellular carcinoma.
    Wu FS, Zhao WH, Liang TB, Ma ZM, Teng LS, Wang M, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2005 Aug 01; 4(3):379-84. PubMed ID: 16109520
    [Abstract] [Full Text] [Related]

  • 11. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Lee WJ, Han KH, Chon CY, Kim BR.
    J Gastroenterol Hepatol; 2009 Mar 01; 24(3):391-8. PubMed ID: 19032452
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
    Shirabe K, Wakiyama S, Gion T, Motomura K, Koyanagi T, Sakamoto S, Nagaie T.
    Hepatogastroenterology; 2007 Mar 01; 54(79):2084-7. PubMed ID: 18251164
    [Abstract] [Full Text] [Related]

  • 13. Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.
    Sonoyama T, Ochiai T, Hironaka T, Yamagishi H.
    Hepatogastroenterology; 2003 Mar 01; 50(52):1078-84. PubMed ID: 12845986
    [Abstract] [Full Text] [Related]

  • 14. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S.
    Cancer; 2005 Jan 15; 103(2):307-12. PubMed ID: 15593087
    [Abstract] [Full Text] [Related]

  • 15. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.
    Li T, Fan J, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY.
    Ann Surg Oncol; 2011 Jul 15; 18(7):1955-63. PubMed ID: 21240562
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
    Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR.
    Ann Surg Oncol; 2008 Feb 15; 15(2):618-29. PubMed ID: 18004628
    [Abstract] [Full Text] [Related]

  • 17. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M.
    Ann Surg Oncol; 2008 May 15; 15(5):1375-82. PubMed ID: 18324443
    [Abstract] [Full Text] [Related]

  • 18. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
    Yao WJ, Wang ST, Chow NH, Chang TT, Lin PW, Tu DG.
    Cancer; 2002 Jul 01; 95(1):112-8. PubMed ID: 12115324
    [Abstract] [Full Text] [Related]

  • 19. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M, Vigano' L, Ferrero A, Pellerito R, Carbonatto P, Capussotti L.
    Eur J Surg Oncol; 2007 Feb 01; 33(1):61-6. PubMed ID: 17175128
    [Abstract] [Full Text] [Related]

  • 20. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep 01; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.